May 15, 2013
/PRNewswire/ -- AMRI (NASDAQ: AMRI) announced today that
Michael M. Nolan
, Vice President, Chief Financial Officer and Treasurer at AMRI, will present at the UBS Global Healthcare Conference on
Wednesday, May 22, 2013
9:00 a.m. ET
An audio webcast of the corporate presentation will be available to investors and interested parties by accessing the company's website at
. This audio webcast will be archived for 90 days following the live presentation.
Albany Molecular Research, Inc. (AMRI) is a global contract research and manufacturing organization offering customers fully integrated drug discovery, development and manufacturing services. For over 21 years, AMRI has demonstrated its adaptability as the pharmaceutical and biotechnology industries have undergone tremendous change in response to multiple challenges. This experience, a track record of success and locations in
the United States
now provides our customers with SMARTSOURCING™, a full range of value-added opportunities providing customers informed decision-making, enhanced efficiency and more successful outcomes at all stages of the pipeline. AMRI has also successfully partnered R&D programs and is actively seeking to out-license its remaining programs for further development. For more information about AMRI, please visit our website at
or follow us on Twitter (@amriglobal).